Cited by 1,793Tuberous Sclerosis Complex ResearchGenetic and rare skin diseases.PI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

The Tuberous Sclerosis Complex

Crino, Peter B., Nathanson, Katherine L., Henske, Elizabeth Petri·2006·New England Journal of Medicine

Open this paper in CoChat — free account

Abstract

The tuberous sclerosis complex (TSC), a multisystem, autosomal dominant disorder affecting children and adults, results from mutations in one of two genes, TSC1 (encoding hamartin) or TSC2 (encoding tuberin). In this article, the current knowledge of the pathogenesis of the disease and its management are discussed.

Integrity signals

Registry

Crossref · 10.1056/nejmra055323

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin
Dan, H. C., Sun, M., Yang, L., Feldman, R. I., Sui, X.-M., Ou, C. C., Nellist, M. D., Yeung, R. S. W., Halley, D. J. J., Nicosia, S. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205838200 · Cited by 370
Retracted
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Self-citation
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,264
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,107

Show all 98 references

Research works printed but not linked: 7

Bourneville DM, 1880, Arch Neurol (Paris), 1, 81
Bjornsson J, 1996, Am J Pathol, 149, 1201
Henske EP, 1996, Am J Hum Genet, 59, 400
Plank TL, 1998, Cancer Res, 58, 4766
Plank TL, 1999, Mod Pathol, 12, 539
Wienecke R, 1996, Oncogene, 13, 913
Liu MY, 2002, Cancer Res, 62, 6475

Sorted by citations

Items 301–400 of 1,001

Epilepsy in TSC : Certain etiology does not mean certain prognosis
Vignoli, A., Briola, F. L., Turner, K., Scornavacca, G. F., Chiesa, V., Zambrelli, E., Piazzini, A., Savini, M. N., Alfano, R. M., & Canevini, M. P. (2013) · Epilepsia · doi:10.1111/epi.12430 · Cited by 77
Brain lesions in tuberous sclerosis complex. Review.
Grajkowska, W., Kotulska, K., Jurkiewicz, E., & Matyja, E. (2010) · PubMed · Cited by 77
Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis
McDaniel, S. S., & Wong, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.037 · Cited by 78
Exploring the mechanisms underlying excitation/inhibition imbalance in human iPSC-derived models of ASD
Culotta, L., & Penzes, P. (2020) · Molecular Autism · doi:10.1186/s13229-020-00339-0 · Cited by 83
Ral GTPases: crucial mediators of exocytosis and tumourigenesis
Shirakawa, R., & Horiuchi, H. (2015) · Journal of Biochemistry · doi:10.1093/jb/mvv029 · Cited by 76
Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex
Major, P., & Thiele, E. A. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.04.001 · Cited by 75
Comprehensive Imaging Manifestations of Tuberous Sclerosis
Manoukian, S. B., & Kowal, D. J. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.13.12235 · Cited by 74
Renal angiomyolipoma without visible fat: Can we make the diagnosis using CT and MRI?
Lim, R. S., Flood, T. A., McInnes, M. D. F., Lavallée, L. T., & Schieda, N. (2017) · European Radiology · doi:10.1007/s00330-017-4988-4 · Cited by 74
Inorganic polyphosphate elicits pro‐inflammatory responses through activation of the mammalian target of rapamycin complexes 1 and 2 in vascular endothelial cells
Hassanian, S. M., Dinarvand, P., Smith, S. A., & Rezaie, A. R. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12899 · Cited by 72
Impaired Language Pathways in Tuberous Sclerosis Complex Patients with Autism Spectrum Disorders
Angeles, W. W. L.-D. L., Şahin, M., Scherrer, B., Peters, J. M., Suarez, R. O., Vogel‐Farley, V. K., Jeste, S., Gregas, M., Prabhu, S. P., Nelson, C. A., et al. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs135 · Cited by 74
Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models
Lee, N. Y., Woodrum, C., Nobil, A. M., Rauktys, A., Messina, M. P., & Dabora, S. L. (2009) · BMC Pharmacology · doi:10.1186/1471-2210-9-8 · Cited by 72
Sunitinib resistance in renal cell carcinoma
Morais, C. (2014) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.2014.7 · Cited by 70
Educational paper
Bergmann, C. (2011) · European Journal of Pediatrics · doi:10.1007/s00431-011-1553-z · Cited by 73
A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes
Scollon, S., Anglin, A. K., Thomas, M. H., Turner, J. T., & Schneider, K. W. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0077-8 · Cited by 72
Long-term outcomes of epilepsy surgery in tuberous sclerosis complex
Liang, S., Zhang, J., Yang, Z., Zhang, S., Cui, Z., Cui, J., Zhang, J., Liu, N., & Ding, P. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8507-y · Cited by 73
TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti–PD-1/anti–CTLA-4 immunotherapy
Liu, H.-J., Lizotte, P. H., Du, H., Speranza, M. C., Lam, H. C., Vaughan, S. W., Alesi, N., Wong, K., Freeman, G. J., Sharpe, A. H., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98674 · Cited by 73
Self-citation
Renal manifestation of tuberous sclerosis complex
Bissler, J. J., & Kingswood, J. C. (2018) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31654 · Cited by 73
Vascular involvement in tuberous sclerosis
Salerno, A. E., Marsenić, O., Meyers, K. E. C., Kaplan, B. S., & Hellinger, J. C. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1466-5 · Cited by 70
Prospects for mTOR-mediated functional repair after central nervous system trauma
Berry, M., Ahmed, Z., Morgan-Warren, P. J., Fulton, D. J., & Logan, A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.002 · Cited by 67
From genes to cognition in tuberous sclerosis: Implications for mTOR inhibitor-based treatment approaches
Ehninger, D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.015 · Cited by 68
mTOR Signaling in Autophagy Regulation in the Kidney
Inoki, K. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.11.002 · Cited by 71
Everolimus alters white matter diffusion in tuberous sclerosis complex
Tillema, J., Leach, J. L., Krueger, D. A., & Franz, D. N. (2012) · Neurology · doi:10.1212/wnl.0b013e318247ca8d · Cited by 69
TBC1D7Mutations are Associated with Intellectual Disability, Macrocrania, Patellar Dislocation, and Celiac Disease
Alfaiz, A. A., Micale, L., Mandriani, B., Augello, B., Pellico, M. T., Chrast, J., Xénarios, I., Zelante, L., Merla, G., & Reymond, A. (2014) · Human Mutation · doi:10.1002/humu.22529 · Cited by 69
MiT Family Translocation-Associated Renal Cell Carcinoma: A Contemporary Update With Emphasis on Morphologic, Immunophenotypic, and Molecular Mimics
Magers, M. J., Udager, A. M., & Mehra, R. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0196-ra · Cited by 69
Constitutive Activation of mTORC1 in Endothelial Cells Leads to the Development and Progression of Lymphangiosarcoma through VEGF Autocrine Signaling
Sun, S., Chen, S., Liu, F., Wu, H., McHugh, J. B., Bergin, I. L., Gupta, A., Adams, D. M., & Guan, J. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.004 · Cited by 69
Ophthalmic manifestations of tuberous sclerosis: a review
Hodgson, N. M., Kinori, M., Goldbaum, M. H., & Robbins, S. L. (2016) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12806 · Cited by 69
Current Approaches and Future Directions for the Treatment of mTORopathies
Karalis, V., & Bateup, H. S. (2021) · Developmental Neuroscience · doi:10.1159/000515672 · Cited by 67
mTOR Activation, Lymphangiogenesis, and Estrogen-Mediated Cell Survival: The “Perfect Storm” of Pro-Metastatic Factors in LAM Pathogenesis
Yu, J. J., & Henske, E. P. (2010) · Lymphatic Research and Biology · doi:10.1089/lrb.2009.0020 · Cited by 68
Self-citation
Specific Killing of Rb Mutant Cancer Cells by Inactivating TSC2
Li, B., Gordon, G. M., Du, C. H., Xu, J., & Du, W. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.019 · Cited by 68
Characterization of the Intrinsic and TSC2-GAP–Regulated GTPase Activity of Rheb by Real-Time NMR
Marshall, C. B., Ho, J., Buerger, C., Plevin, M. J., Li, G., Li, Z., Ikura, M., & Stambolic, V. (2009) · Science Signaling · doi:10.1126/scisignal.2000029 · Cited by 70
mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex
Pema, M., Drusian, L., Chiaravalli, M., Castelli, M., Yao, Q., Ricciardi, S., Somlo, S., Qian, F., Biffo, S., & Boletta, A. (2016) · Nature Communications · doi:10.1038/ncomms10786 · Cited by 70
Smooth Muscle–like Cells in Pulmonary Lymphangioleiomyomatosis
Krymskaya, V. P. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200705-061vs · Cited by 69
The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth, and chemosensitivity under hypoxic conditions
Matthew, E. M., Hart, L. S., Astrinidis, A., Navaraj, A., Dolloff, N. G., Dicker, D. T., Henske, E. P., & El-Deiry, W. S. (2009) · Cell Cycle · doi:10.4161/cc.8.24.10800 · Cited by 67
Self-citation
Activated ERBB2/HER2 Licenses Sensitivity to Apoptosis upon Endoplasmic Reticulum Stress through a PERK-Dependent Pathway
Martín‐Pérez, R., Palacios, C., Yerbes, R., Cano-González, A., Iglesias‐Serret, D., Gil, J., Reginato, M. J., & López‐Rivas, A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1747 · Cited by 68
Tuberous sclerosis complex: the past and the future
Waele, L. D., Lagae, L. G., & Mekahli, D. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-3027-9 · Cited by 67
Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells
Li, C., Lee, P., Sun, Y., Gu, X., Zhang, E. Y., Guo, Y., Wu, C., Auricchio, N., Priolo, C., Li, J., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131080 · Cited by 67
Self-citation
Tuberous sclerosis complex: Recent advances in manifestations and therapy
Wataya‐Kaneda, M., Uemura, M., Fujita, K., Hirata, H., Osuga, K., Kagitani‐Shimono, K., & Nonomura, N. (2017) · International Journal of Urology · doi:10.1111/iju.13390 · Cited by 69
Emerging Treatments in the Management of Tuberous Sclerosis Complex
Kohrman, M. H. (2012) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2012.02.015 · Cited by 66
The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells
Rosilio, C., Lounnas, N., Nebout, M., Imbert, V., Hagenbeek, T. J., Spits, H., Asnafi, V., Pontier-Bres, R., Reverso, J., Michiels, J., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.015 · Cited by 70
Whole-genome sequencing reveals principles of brain retrotransposition in neurodevelopmental disorders
Jacob‐Hirsch, J., Eyal, E., Knisbacher, B. A., Roth, J. F., Cesarkas, K., Dor, C., Barhom, S. F., Kunik, V., Simon, A. J., Gal, M., et al. (2018) · Cell Research · doi:10.1038/cr.2018.8 · Cited by 72
Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration
Reith, R. M., Way, S., McKenna, J., Haines, K., & Gambello, M. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.02.014 · Cited by 65
Increased risk of solid renal tumors in lithium-treated patients
Zaidan, M., Stucker, F., Stengel, B., Vasiliu, V., Hummel, A., Landais, P., Boffa, J., Ronco, P. M., Grünfeld, J., & Servais, A. (2014) · Kidney International · doi:10.1038/ki.2014.2 · Cited by 67
Acral lesions in tuberous sclerosis complex: Insights into pathogenesis
Cs, A., Hong, C., Groves, L., Olsen, C. H., Moss, J., & Darling, T. N. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.08.042 · Cited by 65
Biology of human melanocyte development, Piebaldism, and Waardenburg syndrome
Saleem, M. D. (2018) · Pediatric Dermatology · doi:10.1111/pde.13713 · Cited by 65
Targeted treatment trials for tuberous sclerosis and autism: no longer a dream
Şahin, M. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.04.008 · Cited by 66
Impaired Reelin-Dab1 Signaling Contributes to Neuronal Migration Deficits of Tuberous Sclerosis Complex
Moon, U. Y., Park, J. Y., Park, R., Cho, J. Y., Hughes, L. J., McKenna, J., Goetzl, L. M., Cho, S., Crino, P. B., Gambello, M. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.013 · Cited by 69
Self-citation
The Natural History and Treatment of Epilepsy in a Murine Model of Tuberous Sclerosis
Altay, E. E., Zeng, L., Xu, L., Gutmann, D. H., & Wong, M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01110.x · Cited by 64
Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis
Pollizzi, K. N., Malinowska-Kołodziej, I., Stumm, M., Lane, H. A., & Kwiatkowski, D. J. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-38 · Cited by 64
Epilepsy in Tuberous Sclerosis: Phenotypes, Mechanisms, and Treatments
Sampson, J. R., & Saxena, A. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552616 · Cited by 65
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report
Auvin, S., Bissler, J. J., Cottin, V., Fujimoto, A., Hofbauer, G. F. L., Jansen, A., Jóźwiak, S., Kerecuk, L., Kingswood, J. C., Moavero, R., et al. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1072-y · Cited by 65
Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex
Clement, E. A. V. D. P., Jansen, F. E., Braun, K. P. J., & Peters, J. M. (2020) · Pediatric Drugs · doi:10.1007/s40272-019-00376-0 · Cited by 63
The evolutionarily conserved TSC/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development
Karbowniczek, M., Zitserman, D., Khabibullin, D., Hartman, T. R., Yu, J. J., Morrison, T. A., Nicolas, É., Squillace, R. M., Roegiers, F., & Henske, E. P. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40221 · Cited by 59
Self-citation
Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex in 11 Children: Presentation to Outcome
Kocabaş, A., Ekici, F., Çetin, İ. İ., Emir, S., Demir, H. A., Arı, M. E., Değerli̇yurt, A., & Güven, A. (2012) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2012.734896 · Cited by 63
Rapamycin-Insensitive Up-Regulation of MMP2 and Other Genes in Tuberous Sclerosis Complex 2–Deficient Lymphangioleiomyomatosis-Like Cells
Lee, P., Tsang, S. W., Moses, M. A., Trayes-Gibson, Z., Hsiao, L., Jensen, R. V., Squillace, R. M., & Kwiatkowski, D. J. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0050oc · Cited by 61
Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling
Warren, E. C., Dooves, S., Lugarà, E., Damstra‐Oddy, J., Schaf, J., Heine, V. M., Walker, M. C., & Williams, R. S. B. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008980117 · Cited by 66
Renal Manifestations of Tuberous Sclerosis Complex: Key Findings From the Final Analysis of the TOSCA Study Focussing Mainly on Renal Angiomyolipomas
Kingswood, J. C., Belousova, E., Benedik, M. P., Carter, T., Cottin, V., Curatolo, P., Dahlin, M. G., D’Amato, L., d’Augères, G. B., de Vries, P. J., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00972 · Cited by 62
Diffusion Features of White Matter in Tuberous Sclerosis With Tractography
Krishnan, M. L., Commowick, O., Jeste, S., Weisenfeld, N., Hans, A., Gregas, M. C., Şahin, M., & Warfield, S. K. (2010) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2009.08.001 · Cited by 64
EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients – A prospective study of 5 patients
Domańska‐Pakieła, D., Kaczorowska, M., Jurkiewicz, E., Kotulska, K., Dunin-Wąsowicz, D., & Jóźwiak, S. (2014) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2013.12.006 · Cited by 62
Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin
Kim, S.-H., Speirs, C. K., Solnica‐Krezel, L., & Ess, K. C. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005587 · Cited by 61
Intracellular signalling during female gametogenesis
Sobinoff, A. P., Sutherland, J. M., & McLaughlin, E. A. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas065 · Cited by 65
mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders
Franz, D. N., & Capal, J. K. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0596-2 · Cited by 62
Brain Organoids as Tools for Modeling Human Neurodevelopmental Disorders
Adams, J. W., Cugola, F. R., & Muotri, A. R. (2019) · Physiology · doi:10.1152/physiol.00005.2019 · Cited by 68
Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis
Steagall, W. K., Glasgow, C. G., Hathaway, O. M., Avila, N. A., Taveira‐DaSilva, A. M., Rabel, A., Stylianou, M. P., Lin, J., Chen, X., & Moss, J. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00176.2007 · Cited by 62
The Tuberous Sclerosis Complex
(2007) · New England Journal of Medicine · doi:10.1056/nejmc062928 · Cited by 41
Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis
Sun, P., Kohrman, M. H., Liu, J., Guo, A., Rogerio, J. W., & Krueger, D. A. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.658907 · Cited by 61
MEK-ERK1/2-Dependent FLNA Overexpression Promotes Abnormal Dendritic Patterning in Tuberous Sclerosis Independent of mTOR
Zhang, L., Bartley, C. M., Gong, X., Hsieh, L. S., Lin, T. V., Feliciano, D. M., & Bordey, A. (2014) · Neuron · doi:10.1016/j.neuron.2014.09.009 · Cited by 62
Initiation of neuronal differentiation requires PI3-kinase/TOR signalling in the vertebrate neural tube
Fishwick, K. J., Li, R. A., Halley, P. A., Deng, P., & Storey, K. G. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.12.001 · Cited by 65
Genetic and environmental modulation of neurodevelopmental disorders: Translational insights from labs to beds
Homberg, J. R., Kyzar, E. J., Scattoni, M. L., Norton, W., Pittman, J. T., Gaikwad, S., Nguyen, M., Poudel, M. K., Ullmann, J. F. P., Diamond, D. M., et al. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.015 · Cited by 67
mTOR in health and in sickness
Liko, D., & Hall, M. N. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1326-7 · Cited by 60
Metformin: A metabolic disruptor and anti-diabetic drug to target human leukemia
Rosilio, C., Ben‐Sahra, I., Bost, F., & Peyron, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.006 · Cited by 63
Chemokine-Enhanced Chemotaxis of Lymphangioleiomyomatosis Cells with Mutations in the Tumor Suppressor TSC2 Gene
Pacheco–Rodriguez, G., Kumaki, F., Steagall, W. K., Zhang, Y., Ikeda, Y., Lin, J., Billings, E. M., & Moss, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1270 · Cited by 62
Current Management of Tuberous Sclerosis Complex
Krueger, D., & Franz, D. (2008) · Paediatric drugs · doi:10.2165/00148581-200810050-00004 · Cited by 68
Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex
Zhang, B., Zou, J., Rensing, N. R., Yang, M., & Wong, M. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.016 · Cited by 61
Neuropsychological attention deficits in tuberous sclerosis complex (TSC)
de Vries, P. J., GARDINER, J. S., & Bolton, P. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32690 · Cited by 59
Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons
Rüegg, S. J., Baybis, M., Juul, H., Dichter, M. A., & Crino, P. B. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.09.009 · Cited by 59
Self-citation
Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy
Ryther, R. C. C., & Wong, M. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0276-5 · Cited by 60
Sirolimus and Temsirolimus for Epithelioid Angiomyolipoma
Wolff, N. C., Kabbani, W., Bradley, T. P., Raj, G. V., Watumull, L. M., & Brugarolas, J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3061 · Cited by 59
Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide
Parkhitko, A. A., Priolo, C., Coloff, J. L., Yun, J., Wu, J. J., Mizumura, K., Xu, W., Malinowska, I. A., Yu, J. J., Kwiatkowski, D. J., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0258-t · Cited by 58
Self-citation
Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
Franz, D. N. (2013) · Biologics · doi:10.2147/btt.s25095 · Cited by 59
Molecular Pathways and Therapies in Autosomal-Dominant Polycystic Kidney Disease
Saigusa, T., & Bell, P. D. (2015) · Physiology · doi:10.1152/physiol.00032.2014 · Cited by 60
Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis
Liśkiewicz, A., Liśkiewicz, D., Wojakowska, A., Polański, K., Lewin‐Kowalik, J., Kotulska, K., & Jędrzejowska–Szypułka, H. (2016) · Scientific Reports · doi:10.1038/srep21807 · Cited by 58
Regulation of PERK–eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytes
Jiang, M., Liu, L., He, X., Wang, H., Lin, W., Wang, H., Yoon, S. O., Wood, T. L., & Lu, Q. R. (2016) · Nature Communications · doi:10.1038/ncomms12185 · Cited by 59
Cutaneous manifestations of tuberous sclerosis complex and the paediatrician's role
Cardis, M. A., & DeKlotz, C. M. C. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-312001 · Cited by 59
Molecular Therapies for Tuberous Sclerosis and Neurofibromatosis
Franz, D. N., & Weiss, B. D. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0269-4 · Cited by 58
Tuberous Sclerosis: Current Update
Wang, M. X., Segaran, N. L., Bhalla, S., Pickhardt, P. J., Lubner, M. G., Katabathina, V. S., & Ganeshan, D. (2021) · Radiographics · doi:10.1148/rg.2021210103 · Cited by 58
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
Alesi, N., Khabibullin, D., Rosenthal, D. M., Akl, E. W., Cory, P. M., Alchoueiry, M., Salem, S., Daou, M., Gibbons, W. F., Chen, J. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44229-4 · Cited by 61
Self-citation
A Case of Solitary Subependymal Giant Cell Astrocytoma
Ichikawa, T., Wakisaka, A., Daido, S., Takao, S., Tamiya, T., Date, I., Koizumi, S., & Niida, Y. (2005) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60586-7 · Cited by 58
Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus
Mlczoch, E., Hanslik, A., Luckner, D., Kitzmüller, E., Prayer, D., & Michel‐Behnke, I. (2014) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.13434 · Cited by 58
Nervous system involvement in von Hippel–Lindau disease: pathology and mechanisms
Vortmeyer, A. O., Falke, E., Gläsker, S., Li, J., & Oldfield, E. H. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1091-z · Cited by 57
Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin
McNamara, E. K., Curtis, A. R., & Fleischer, A. B. (2010) · Journal of Dermatological Treatment · doi:10.3109/09546634.2010.489598 · Cited by 58
Tuberous sclerosis complex
Hasbani, D. M., & Crino, P. B. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00052-1 · Cited by 58
Self-citation
Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2
Bissler, J. J., Budde, K., Sauter, M., Franz, D. N., Zonnenberg, B. A., Frost, M., Белоусова, Е. Д., Berkowitz, N. C., Ridolfi, A., & Kingswood, J. C. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy132 · Cited by 58
STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth
Li, H., Liu, P., Li, D., Wang, Z., Ding, Z., Zhou, M., Chen, X., Miao, M., Ding, J., Lin, W., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02513-z · Cited by 57
Importance of Preclinical Research in the Development of Neuroprotective Strategies for Ischemic Stroke
Neuhaus, A. A., Rabie, T., Sutherland, B. A., Papadakis, M., Hadley, G., Cai, R., & Buchan, A. M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6299 · Cited by 57
Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio‐temporal lobe epilepsy
Shima, A., Nitta, N., Suzuki, F., Laharie, A., Nozaki, K., & Depaulis, A. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12835 · Cited by 57
Role of LKB1 in lung cancer development
Makowski, L., & Hayes, D. N. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604515 · Cited by 59
Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation
Cao, J., Tyburczy, M. E., Moss, J., Darling, T. N., Widlund, H. R., & Kwiatkowski, D. J. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84262 · Cited by 57
Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex
Arulrajah, S., Ertan, G., Jordan, L. C., Tekes, A., Khaykin, E., Izbudak, I., & Huisman, T. A. G. M. (2009) · Neuroradiology · doi:10.1007/s00234-009-0563-2 · Cited by 57
Systemic Disease and the Skin
Graham, R. M., & Cox, N. H. (2004) · Wiley eBooks · doi:10.1002/9780470750520.ch59 · Cited by 55
Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population
McMaster, M. L., Goldstein, A. M., & Parry, D. M. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.085092 · Cited by 56

Authors: Crino, P. B., Nathanson, K. L., & Henske, E. P.
Affiliations: University of Pennsylvania Health System (US)
University of Pennsylvania (US)
Fox Chase Cancer Center (US)
ORCID: Crino, Peter B.
Nathanson, Katherine L.
Henske, Elizabeth Petri
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2006-09-28
Volume: 355
Issue: 13
Pages: 1345-1356
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra055323
OpenAlex: W2383259826
Cited by: 1,793
References: 98
Citations by year: 2026: 39 · 2025: 61 · 2024: 73 · 2023: 61 · 2022: 79 · 2021: 96 · 2020: 94 · 2019: 67 · 2018: 95 · 2017: 101 · 2016: 102 · 2015: 109 · 2014: 119 · 2013: 146 · 2012: 129
FWCI: 7.94
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL60746, R01HL060746)
National Institute of Diabetes and Digestive and Kidney Diseases (DK-51052)
National Institute of Neurological Disorders and Stroke (NS045021, R01NS045021)
Topics: Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: tuberous sclerosis complex, TSC1, hamartin, TSC2, tuberin, autosomal dominant disorder, pathogenesis, disease management, multisystem disease
MeSH terms: Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Estrogens, Female, Humans, Genetic Linkage, Male, Mutation, Protein Kinases, Tuberous Sclerosis, Signal Transduction, Tumor Suppressor Proteins, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Tuberous Sclerosis Complex

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks